The mechanism of the negative regulation of
proopiomelanocortin gene (
Pomc) by
glucocorticoids (Gcs) is still unclear in many points. Here, we demonstrated the involvement of
neurogenic differentiation factor 1 (NeuroD1) in the Gc-mediated negative regulation of
Pomc. Murine pituitary
adrenocorticotropic hormone (
ACTH) producing corticotroph
tumor-derived AtT20 cells were treated with
dexamethasone (DEX) (1-100 nM) and cultured for 24 hrs. Thereafter,
Pomc mRNA expression was studied by quantitative real-time PCR and rat
Pomc promoter (-703/+58) activity was examined by
luciferase assay. Both
Pomc mRNA expression and
Pomc promoter activity were inhibited by DEX in a dose-dependent manner. Deletion and point mutant analyses of
Pomc promoter suggested that the DEX-mediated transcriptional repression was mediated via E-box that exists at -376/-371 in the promoter. Since NeuroD1 is known to bind to and activate E-box of the
Pomc promoter, we next examined the effect of DEX on NeuroD1 expression. Interestingly, DEX dose-dependently inhibited NeuroD1
mRNA expression, mouse NeuroD1 promoter (-2.2-kb) activity, and
NeuroD1 protein expression in AtT20 cells. In addition, we confirmed the inhibitory effect of DEX on the interaction of NeuroD1 and E-box on
Pomc promoter by
chromatin immunoprecipitation (ChIP) assay. Finally, overexpression of mouse NeuroD1 could rescue the DEX-mediated inhibition of
Pomc mRNA expression and
Pomc promoter activity. Taken together, it is suggested that the suppression of NeuroD1 expression and the inhibition of NeuroD1/E-box interaction may play an important role in the Gc-mediated negative regulation of
Pomc.